Robert Klupacs

Robert Klupacs

Directeur Général chez Bionics Institute

Health Technology
Consumer Services
Commercial Services

Profil

Robert Klupacs was the founder of ES Cell International Pte Ltd.
(founded in 2000) and held the title of Chief Executive Officer from 2010 to 2011.
He is currently the Chief Executive Officer at Bionics Institute since 2017, Chairman at Syngene Ltd.
since 2012, and a Member at The Australian Institute for Performing Arts.
Previously, he was the Chairman at Bio-Gene Technology Ltd.
from 2020 to 2023, Executive Director at Opthea Ltd.
from 2005 to 2013, Director-Intellectual Property & Member at Amrad Pharmaceuticals Pty Ltd.
from 1988 to 1999, and Chief Operating Officer at Monash Institute of Medical Research in 2001.
He is also a Member of the Pharmaceuticals Industry Council.
Mr. Klupacs completed his undergraduate degree at Monash University.

Postes actifs de Robert Klupacs

SociétésPosteDébut
The Australian Institute for Performing Arts Corporate Officer/Principal 18/02/2011
Président -
Directeur Général 18/05/2017
Tous les postes actifs de Robert Klupacs

Anciens postes connus de Robert Klupacs

SociétésPosteFin
BIO-GENE TECHNOLOGY LIMITED Directeur Général -
OPTHEA LIMITED Directeur Général 03/12/2013
Monash Institute of Medical Research Directeur des opérations 01/01/2001
Corporate Officer/Principal 01/01/1999
Corporate Officer/Principal -
Voir l'expérience en détail de Robert Klupacs

Formation de Robert Klupacs

Monash University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Robert Klupacs

Relations

40

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
OPTHEA LIMITED

Health Technology

BIO-GENE TECHNOLOGY LIMITED

Process Industries

Entreprise privées7

Health Technology

Health Technology

The Australian Institute for Performing Arts

Monash Institute of Medical Research

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Robert Klupacs
-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT